Steven Cohen’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.03M Buy
+668,463
New +$6.78M 0.01% 1805
2026
Q2
– Sell
-139,791
Closed -$1.17M – 4494
2026
Q1
$1.17M Buy
139,791
+106,407
+319% +$1.12M ﹤0.01% 2668
2025
Q4
$481K Buy
+33,384
New +$416K ﹤0.01% 3256
2025
Q1
– Sell
-200
Closed -$1.55K – 2455
2024
Q4
$1.55K Buy
+200
New +$1.88K ﹤0.01% 2038
2024
Q2
– Sell
-1,600
Closed -$33.7K – 2349
2024
Q1
$33.7K Buy
+1,600
New +$28.5K ﹤0.01% 2084
2023
Q3
– Sell
-7
Closed -$140 – 2806
2023
Q2
$140 Buy
+7
New +$135 ﹤0.01% 2051
2022
Q4
– Sell
-18,500
Closed -$489K – 1748
2022
Q3
$489K Sell
18,500
-549,000
-97% -$16.3M ﹤0.01% 1174
2022
Q2
$14M Buy
567,500
+50,233
+10% +$1.25M 0.06% 408
2022
Q1
$17.2M Buy
+517,267
New +$14.4M 0.07% 366
2021
Q3
– Sell
-163,608
Closed -$6.36M – 1208
2021
Q2
$6.36M Sell
163,608
-742,692
-82% -$26.6M 0.03% 557
2021
Q1
$30.9M Buy
906,300
+773,100
+580% +$33M 0.14% 187
2020
Q4
$6.04M Buy
+133,200
New +$4.65M 0.03% 551
2020
Q3
– Sell
-183,756
Closed -$6.77M – 1072
2020
Q2
$6.77M Buy
+183,756
New +$6.85M 0.04% 423
2017
Q3
– Sell
-313,586
Closed -$6.19M – 1026
2017
Q2
$6.19M Buy
313,586
+290,186
+1,240% +$5.62M 0.03% 478
2017
Q1
$452K Buy
+23,400
New +$451K ﹤0.01% 772

Other funds holding RGNX

Steven Cohen's RGNX Position: Q3 2026 in Review

Steven Cohen opened a new position in Regenxbio (RGNX) in Q3 2026: 668,463 shares worth $5.03M. The stake represents 0.01% of the portfolio and ranks #1805 among its holdings. This is a return to the name: Steven Cohen previously reported a position in RGNX as recently as Q1 2026.

Steven Cohen first reported a position in RGNX in Q1 2017 and has held it in 15 quarters since. The position peaked at $30.9M in Q1 2021. 173 funds tracked by Wall St. Rank hold RGNX as of Q3 2026.

  • Steven Cohen held 668,463 shares of Regenxbio worth $5.03M as of Q3 2026.
  • Regenxbio was a new Steven Cohen position in Q3 2026.
  • Regenxbio made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1805 holding.
  • Steven Cohen first reported a position in Regenxbio in Q1 2017 and has held it in 15 quarters since.
  • Steven Cohen's Regenxbio position peaked at $30.9M in Q1 2021.
  • 173 funds tracked by Wall St. Rank held Regenxbio as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.